Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Cancer Res. 2010 Oct 12;70(21):8948–8958. doi: 10.1158/0008-5472.CAN-10-1936

Figure 2.

Figure 2

Cell-surface integrin expression in 468/uPAR cells is inhibited by antagonizing PI3K or MEK. 468/EV and 468/uPAR cells were treated with LY294002 (10 µM), PD098059 (50 µM) or vehicle for 18 h. β1/CD29, activated β1, and α6/CD49f were determined by flow cytometry. The results are representative of three independent experiments.